Home » Corporate Overview »

Corporate Profile

Viropro Inc. (“Viropro”) operates through Viropro International Inc., a Canadian company with its Head Office in Montreal.

Viropro International Inc. is specialized in the technology transfer, for industrial production, of affordable biological therapeutic products (also named biogeneric products, biogenerics, biopharmaceuticals or biotherapeutics) whose licenses have expired.  The principal objective is to support pharmaceutical companies in South America, Asia, Africa and Eastern Europe by offering them the opportunity to locally produce and commercialize biotherapeutic products of industrial quality at an affordable price.  Viropro enables emerging markets with unmet medical needs to gain access to biotherapeutics for the treatment of various diseases such as cancer, diabetes, chronic hepatitis, multiple sclerosis, and rheumatoid arthritis.

The innovative business strategy of Viropro is based on the acquisition of exclusive products and technological licenses/patents, simultaneously with the development of key partnerships with pre-eminent players on a national and international scale.  Viropro has already concluded an agreement with the Biotechnological Research Institute of the National Council of Canada (Montreal: Worldwide exclusive rights to the use of patented expression systems for the production of human Interferon beta and monoclonal antibodies; scale-up and production processes).